SEIA for Life Sciences & Pharma

The Challenge

​

The pharmaceutical and life sciences industry operates at the intersection of global trade and public health. You're exporting controlled substances, dual-use research equipment, and sensitive technologies to markets around the world — each with its own regulatory requirements, licensing obligations, and sanctions considerations.

​

At the same time, the pressure to move quickly is immense. Delays caused by compliance bottlenecks can have real consequences — not just for revenue, but for patient access to critical medicines and therapies. The challenge is ensuring rigorous compliance without slowing down the speed of business.

 

Adding to the complexity, sanctions and export controls increasingly intersect with the pharma industry in unexpected ways. Humanitarian exemptions are nuanced. End-use and end-user screening must be thorough. And regulators expect companies to demonstrate not just compliance, but a genuine culture of risk awareness.

​

How SEIA Supports Pharma & Life Sciences

​

Navigate Humanitarian Exemptions With Confidence- Sanctions regimes often include carve-outs for medical goods and humanitarian aid, but the details are complex and vary by jurisdiction. SEIA helps you understand where your transactions fall within these frameworks, reducing the risk of both over-compliance (which delays access to medicines) and under-compliance (which creates legal exposure).

​

Targeted Due Diligence- By analyzing your transaction data holistically, SEIA helps identifies risk patterns based on real data and real business behaviour— like unusual shipping routes, odd volumes or product combinations, intermediary red flags, end-use concerns — that point-in-time screening tools miss because they are only focused on lists and ownership structures. 

​

Support Regulatory Interactions With Data- Whether you're responding to an inquiry, preparing a voluntary disclosure, or applying for a license, SEIA provides the data-driven evidence you need to demonstrate the strength and effectiveness of your compliance program.

​

Align Compliance With Commercial Goals- We understand that in pharma, compliance isn't just about avoiding penalties — it's about enabling access. SEIA helps you find the balance between rigorous risk management and operational agility, so compliance supports rather than hinders your mission.

​

Who Benefits

​

• Compliance Officers get a powerful tool that automates risk identification and reduces the burden of manual transaction reviews, especially for high-volume global operations.

​

• ​C-Suite Leaders gain visibility into compliance program performance and confidence that the organization's risk posture is strong and defensible.

​

• Legal & General Counsel receive structured, data-backed insights that support licensing, enforcement response, and regulatory strategy.

​​

• Customers & Patients get the medical care they need when business runs smoothly

 

Why It Matters Now

Enforcement authorities are expanding their focus on the pharmaceutical sector, particularly in relation to sanctions on Russia, Iran, and other jurisdictions. Companies that assumed their products were low-risk under export control classifications are discovering that end-use, end-user, and diversion risks still apply. A proactive, data-driven approach to compliance is no longer optional — it's expected.

​

Let's Talk About Your Compliance Challenges

Every pharmaceutical company's risk profile is different. We'd welcome the chance to understand yours and explore how SEIA can support your program.

​​